Stock Events

Stock Events

Ginkgo Bioworks 

$8.98
566
-$0.07-0.77% 15:51 Today

Statistics

Day High
9.2
Day Low
8.86
52W High
17.58
52W Low
5.37
Volume
14,122,831
Avg. Volume
-
Mkt Cap
586.61M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-2.73
-2.12
-1.52
-0.91
Expected EPS
-0.91
Actual EPS
N/A

Financials

-183.81%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
170.16MRevenue
-312.76MNet Income

Analyst Ratings

5.00Average Price Target
The highest estimate is 5.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
0%
Sell
100%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DNA. It's not an investment recommendation.
Tesla
90
TSLA
Palantir Technologies
86
PLTR
NVIDIA
83
NVDA
Apple
77
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Twist Bioscience
TWST
Mkt Cap5.64B
Twist Bioscience Corporation operates in the synthetic biology field, offering DNA synthesis products that compete with Ginkgo Bioworks' platform for programming cells.
Synlogic
SYBX
Mkt Cap8.32M
Synlogic, Inc. is engaged in the development of therapeutics that leverage synthetic biology, competing in the biotech space where Ginkgo Bioworks also operates.
Codexis
CDXS
Mkt Cap220.88M
Codexis, Inc. specializes in protein engineering and enzyme optimization, competing with Ginkgo Bioworks in the field of bio-catalysis and bio-manufacturing.
Evogene
EVGN
Mkt Cap6.2M
Evogene Ltd. applies computational biology and synthetic biology to develop products in agriculture, competing with Ginkgo Bioworks in the agri-biotech sector.
Pacific Biosciences of California
PACB
Mkt Cap484.54M
Pacific Biosciences of California, Inc. provides sequencing systems that compete with Ginkgo Bioworks' offerings in the genomics and genetic engineering space.
Illumina
ILMN
Mkt Cap28.78B
Illumina, Inc. is a leader in genomics and DNA sequencing technologies, indirectly competing with Ginkgo Bioworks by enabling synthetic biology research and applications.
CRISPR Therapeutics
CRSP
Mkt Cap5.25B
CRISPR Therapeutics AG focuses on gene editing technologies, competing in the broader biotech space for genetic engineering applications, overlapping with Ginkgo's market.
Editas Medicine
EDIT
Mkt Cap500.29M
Editas Medicine, Inc. is involved in gene editing, competing in the genetic modification space, which is relevant to Ginkgo Bioworks' synthetic biology applications.

About

Ginkgo Bioworks Holdings, Inc., alongside its subsidiary entities, provides an advanced technological platform focused on the engineering of cells. This proprietary system is utilized to manipulate cellular functions, facilitating the biological creation of various products. These outputs span from innovative pharmaceutical treatments and vital food components to sustainable chemicals designed to replace those traditionally sourced from petroleum. The enterprise caters to a broad spectrum of industries, encompassing specialized chemical manufacturing, the agricultural sector, food production, consumer goods, and pharmaceuticals. Furthermore, Ginkgo Bioworks has forged a partnership with Selecta Biosciences, Inc., for the joint advancement of the ImmTOR technology platform. The company, founded in 2008, is headquartered in Boston, Massachusetts.
Show more...
CEO
Dr. Jason Kelly Ph.D.
Employees
485
Country
United States
ISIN
US37611X2099

Listings

XNYS
US
DNA
MX
MX
DNA.MX
BOATS
BOATS
DNA.BOATS
OTC Link
US
DNABW

0 Comments

Share your thoughts

FAQ

What is Ginkgo Bioworks stock price today?▼
The current price of DNA is $8.98 USD — it has decreased by -0.77% in the past 24 hours. Watch Ginkgo Bioworks stock price performance more closely on the chart.
What is Ginkgo Bioworks stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Ginkgo Bioworks stocks are traded under the ticker DNA.
Is Ginkgo Bioworks stock price growing?▼
DNA stock has fallen by -3.85% compared to the previous week, the month change is a +13.81% rise, over the last year Ginkgo Bioworks has showed a -9.66% decrease.
What is Ginkgo Bioworks market cap?▼
Today Ginkgo Bioworks has the market capitalization of 586.61M
When is the next Ginkgo Bioworks earnings date?▼
Ginkgo Bioworks is going to release the next earnings report on August 06, 2026.
What were Ginkgo Bioworks earnings last quarter?▼
DNA earnings for the last quarter are -1.39 USD per share, whereas the estimation was -1.21 USD resulting in a -14.77% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Ginkgo Bioworks revenue for the last year?▼
Ginkgo Bioworks revenue for the last year amounts to 170.16M USD.
What is Ginkgo Bioworks net income for the last year?▼
DNA net income for the last year is -312.76M USD.
How many employees does Ginkgo Bioworks have?▼
As of July 14, 2026, the company has 485 employees.
In which sector is Ginkgo Bioworks located?▼
Ginkgo Bioworks operates in the Health & Wellness sector.
When did Ginkgo Bioworks complete a stock split?▼
The last stock split for Ginkgo Bioworks was on August 20, 2024 with a ratio of 1:40.
Where is Ginkgo Bioworks headquartered?▼
Ginkgo Bioworks is headquartered in Boston, United States.